Your browser doesn't support javascript.
loading
A novel mutation of the erythropoietin receptor gene associated with primary familial and congenital polycythaemia.
O'Rourke, Kacey; Fairbairn, David J; Jackson, Kathryn A; Morris, Kirk L; Tey, Siok-Keen; Kennedy, Glen A.
Afiliação
  • O'Rourke K; Department of Haematology, Royal Brisbane and Women's Hospital, Butterfield St, Herston, QLD, 4029, Australia. kaceyorourke@gmail.com.
  • Fairbairn DJ; Department of Haematology, Royal Brisbane and Women's Hospital, Butterfield St, Herston, QLD, 4029, Australia.
  • Jackson KA; Department of Haematology, Royal Brisbane and Women's Hospital, Butterfield St, Herston, QLD, 4029, Australia.
  • Morris KL; Department of Haematology, Royal Brisbane and Women's Hospital, Butterfield St, Herston, QLD, 4029, Australia.
  • Tey SK; Department of Haematology, Royal Brisbane and Women's Hospital, Butterfield St, Herston, QLD, 4029, Australia.
  • Kennedy GA; Department of Haematology, Royal Brisbane and Women's Hospital, Butterfield St, Herston, QLD, 4029, Australia.
Int J Hematol ; 93(4): 542-544, 2011 Apr.
Article em En | MEDLINE | ID: mdl-21437635
Primary familial and congenital polycythaemia (PFCP) is a rare form of inherited erythrocytosis caused by heterozygous mutations in the erythropoietin receptor gene (EPOR). We present a novel mutation in the EPOR in a 15-year-old male who was referred to our clinic for investigation of a persistently elevated haemoglobin level. A significant family history of unexplained erythrocytosis spanning four generations of the patient's family was established. The family history was also significant for an apparent increased rate of cerebrovascular disease in individuals with erythrocytosis. The mutation detected in our patient resides in exon 8 of EPOR, similar to all other EPOR mutations responsible for PFCP. These mutations result in truncation of the cytoplasmic domain of the receptor and impair down-regulation of signalling via the erythropoietin receptor (EPOR). Clinical manifestations in published cases have varied widely and there is a paucity of firm recommendations regarding the management of affected patients. Given the strong family history of complications attributable to erythrocytosis we have recommended venesection with a haematocrit target of ≤0.45 for our patient.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Policitemia / Mutação da Fase de Leitura / Receptores da Eritropoetina Idioma: En Ano de publicação: 2011 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Policitemia / Mutação da Fase de Leitura / Receptores da Eritropoetina Idioma: En Ano de publicação: 2011 Tipo de documento: Article